Congrats and happy to hear it. I know several who've undergone the antibody infusions with similar stories/outcomes. Anecdotally, the existing mABs are *very* effective.
Same here with monoclonal antibodies and with same success. Although the current infusion is not the antibodies of ENZC (not approved yet) those who have been treated have a high success rate. When ENZC's antibodies are available they will be fully human antibodies and not involved with the current process of using mice. Great future here with multiple uses for both human and animals. It is the medicine of the future!
News 
Market Data 
Discover 
AI
